|
Upon the successful completion of the Mylan-Matrix transaction, Matrix Chairman N. Prasad joined the executive team at Mylan as the Head of Global Strategies in the Office of the CEO. Mr. Prasad also serves on Mylan’s Board of Directors and is the Non-Executive Vice Chairman of the Board at Matrix.
Mr. Prasad began his career in 1984 as a Management Trainee with the Indian Molasses Company. In 1989, he joined the India division of Rhone Poulenc Chemicals, a French chemical and pharmaceutical company now known as Sanofi-Aventis, as an Area Sales Officer. He was soon promoted to Regional Sales Manager and was based in Hyderabad. In 1995, he became Managing Director of the active pharmaceutical ingredient (API) manufacturer Vorin Laboratories Limited of India.
Shortly thereafter, Mr. Prasad built a reputation as a change agent highlighted by the turnaround of Matrix Laboratories Limited, now part of Mylan Inc. Mr. Prasad steered the transformation of Matrix Laboratories from a $1 million (market capitalization) API company into a $1 billion global pharmaceutical business in a span of only six years. Among other recognition, the Indian equity research firm Motilal Oswal Securities presented the “Fastest Wealth Creator” award to Matrix Laboratories in 2004, 2005 and 2006.
Mr. Prasad earned a master's degree in science from Delhi University and an MBA from the Institute of Management and Technology on Ghaziabad, India.
| 